Clinical Trial Update: Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial evaluating the combination of homoharringtonine with androgen deprivation therapy as neoadjuvant treatment for prostate cancer; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Homoharringtonine (homoharringtonine)

Snippet

Sponsor: baotai Liang | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING